SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103. A total of 133 filers reported holding SYNAGEVA BIOPHARMA CORP in Q1 2015. The put-call ratio across all filers is 3.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $15,797,000 | -29.0% | 161,970 | -32.4% | 0.41% | -28.5% |
| Q4 2014 | $22,238,000 | +46.2% | 239,660 | +8.4% | 0.57% | +37.2% |
| Q3 2014 | $15,212,000 | -27.7% | 221,169 | +10.1% | 0.42% | -30.6% |
| Q2 2014 | $21,045,000 | +127.4% | 200,813 | +80.0% | 0.60% | +99.7% |
| Q1 2014 | $9,256,000 | -38.5% | 111,556 | -52.0% | 0.30% | -35.7% |
| Q4 2013 | $15,046,000 | +134.2% | 232,475 | +129.4% | 0.47% | +121.8% |
| Q3 2013 | $6,425,000 | +886.9% | 101,350 | +553.9% | 0.21% | +20.6% |
| Q2 2013 | $651,000 | – | 15,500 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|